Article
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
PloS one - 1 Jan 2015
Estrabaud Emilie, Appourchaux Kevin, Bièche Ivan, Carrat Fabrice, Lapalus Martine, Lada Olivier, Martinot-Peignoux Michelle, Boyer Nathalie, Marcellin Patrick, Vidaud Michel, Asselah Tarik
Abstract excerpt
Although, the treatment of chronic hepatitis C (CHC) greatly improved with the use of direct antiviral agents, pegylated-interferon (PEG-IFN) plus ribavirin remains an option for many patients, worldwide. The intra-hepatic level of expression of interferon stimulated genes (ISGs) and the rs129798...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
